Results 61 to 70 of about 205,027 (361)
Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives
Ophthalmologica, 2021 Among older adults, age-related macular degeneration (AMD) is a prevalent disabling condition that begins as subtle visual disturbances and can progress to permanent loss of central vision.
R. Flores +4 more
semanticscholar +1 more source
Acta ophthalmologica, 2021 This study aimed to determine the efficacy of a multimodal deep learning (DL) model using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) images for the assessment of choroidal neovascularization (CNV) in ...
Kai Jin +9 more
semanticscholar +1 more source
Age-related macular degeneration: therapeutic modalities [PDF]
, 2001 To describe the clinical and surgical therapeutic modalities in age-related macular degeneration (ARMD).Descrever as modalidades de tratamento clínico e cirúrgico das complicações da degeneração macular relacionada à idade (DMRI).Universidade Federal de ...
Costa, Rogerio Alves +3 more
core +2 more sources
Association of sildenafil use with age-related macular degeneration: a retrospective cohort study
BMJ Open OphthalmologyObjective Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)—a major cause of global blindness—lacks effective treatment to prevent the irreversible degeneration of ...
Nicola Jaime Adderley +6 more
doaj +1 more source
Age-Related Macular Degeneration: Role of Oxidative Stress and Blood Vessels
International Journal of Molecular Sciences, 2021 Age-related macular degeneration (AMD) is a common irreversible ocular disease characterized by vision impairment among older people. Many risk factors are related to AMD and interact with each other in its pathogenesis.
Yue Ruan, Subao Jiang, A. Gericke
semanticscholar +1 more source
Photo-damage, photo-protection and age-related macular degeneration [PDF]
, 2015 Age-related macular degeneration (AMD) is a degenerative retinal disease that causes blindness in people 60-65 years and older, with the highest prevalence appearing in people 90 years-old or more.
Marquioni Ramella, Melisa Daniela +1 more
core +1 more source
Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article [PDF]
, 2017 Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for neovascular age-related macular degeneration (nAMD).
Elena Gusson +8 more
core +1 more source
PLoS ONE, 2023 BackgroundAge-related macular degeneration is the primary cause of irreversible blindness in developed countries, whereas the global prevalence of osteoporosis-a major public health problem-is 19.7%.
Agnieszka Budnik +9 more
doaj +1 more source
EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration
International Journal of Molecular Sciences, 2020 Epithelial–mesenchymal transition (EMT) and endothelial–mesenchymal transition (EndMT) are physiological processes required for normal embryogenesis. However, these processes can be hijacked in pathological conditions to facilitate tissue fibrosis and ...
Daisy Y. Shu +2 more
semanticscholar +1 more source
Analysis of the Awareness and Access of Eye Healthcare in Underserved Populations
VisionIntroduction: Visual impairment impacts millions of people around the world, with the vast majority of problems being treatable. Disadvantaged communities are unable to utilize the same resources to treat these problems due to a lack of knowledge or ...
Karen Allison +3 more
doaj +1 more source